Anna C. Pavlick
Impact in
- Oncology top 0.2%
- Cancer Immunotherapy and Biomarkers
- Cutaneous Melanoma Detection and Management
- CAR-T cell therapy research
- Immunology top 1%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
Papers in
- Oncology 173
- Cancer Immunotherapy and Biomarkers 78
- CAR-T cell therapy research 60
- Cutaneous Melanoma Detection and Management 55
- Immunology 53
- Immunotherapy and Immune Responses 51
- Co-authors
- Iman OsmanRichard L. ShapiroRussell S. BermanJeffrey S. WeberPatrick A. OttFarbod DarvishianDavid PolskyOmid Hamid
- Journals
- Journal of Clinical Oncology (56 papers)Annals of Oncology (16 papers)Clinical Cancer Research (11 papers)Melanoma Research (8 papers)Cancer Research (7 papers)
- Partner nations
- United StatesAustraliaGermany
In The Last Decade
Anna C. Pavlick
211 papers receiving 8.7k citations
Hit Papers
Peers
Comparison fields: 5 of 129
- Oncology 5.8k
- Immunology 2.2k
- Cancer Research 1.2k
- Molecular Biology 4.7k
- Genetics 457
Countries citing papers authored by Anna C. Pavlick
This map shows the geographic impact of Anna C. Pavlick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna C. Pavlick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna C. Pavlick more than expected).
Fields of papers citing papers by Anna C. Pavlick
This network shows the impact of papers produced by Anna C. Pavlick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna C. Pavlick. The network helps show where Anna C. Pavlick may publish in the future.
Co-authors
The 25 scholars most cited alongside Anna C. Pavlick, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2023 | 6 | |
| 3 | 2021 | 9 | |
| 4 | 2020 | 114 | |
| 5 | 2019 | 56 | |
| 6 | 2019 | 30 | |
| 7 | MHC proteins confer differential sensitivity to CTLA-4 and PD-1 blockade in untreated metastatic melanoma Hit paper breakdown → | 2018 | 408 |
| 8 | 2015 | 30 | |
| 9 | 2015 | 65 | |
| 10 | 2015 | 7 | |
| 11 | 2014 | 51 | |
| 12 | 2013 | 132 | |
| 13 | 2012 | 356 | |
| 14 | 2011 | 56 | |
| 15 | 2011 | 9 | |
| 16 | 2010 | 173 | |
| 17 | 2009 | 34 | |
| 18 | 2009 | 54 | |
| 19 | 2008 | 46 | |
| 20 | Expression of the cancer/testis antigen NY-ESO-1 in primary and metastatic malignant melanoma (MM)--correlation with prognostic factors. | 2007 | 97 |
About Anna C. Pavlick
Anna C. Pavlick is a scholar working on Oncology, Immunology, Cancer Research, Molecular Biology and Immunology and Allergy, having authored 219 papers that have together received 8.9k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (78 papers), Melanoma and MAPK Pathways (69 papers), CAR-T cell therapy research (60 papers), Cutaneous Melanoma Detection and Management (55 papers), Immunotherapy and Immune Responses (51 papers), vaccines and immunoinformatics approaches (20 papers), Cancer Genomics and Diagnostics (16 papers) and Brain Metastases and Treatment (14 papers). The work is most often cited by research in Oncology (5.8k citations), Immunology (2.2k citations), Cancer Research (1.2k citations), Molecular Biology (4.7k citations) and Genetics (457 citations). Anna C. Pavlick has collaborated with scholars based in United States, Australia and Germany. Frequent co-authors include Iman Osman, Richard L. Shapiro, Russell S. Berman, Jeffrey S. Weber, Patrick A. Ott, Farbod Darvishian, David Polsky, Omid Hamid, Steven O’Day and Michael Millward. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Clinical Cancer Research, Melanoma Research and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.